The blog Inside Facebook has a lengthy post up today looking at the marketing efforts of pharmaceutical companies on the social network. Sara Ines Calderon writes:
Pharmaceutical companies have begun creating a presence on Facebook characterized by control and caution. Why? Despite unclear regulations in the U.S. governing their presence online, they may still be penalized for marketing materials on the Internet. The result is, in terms of their Facebook marketing content, a mixed bag of sometimes disingenuous Pages and Groups, fluffy applications and tightly-controlled discussions.
A number of examples follow.
